Genprex
significantly reduced tumor growth | Genprex
Company
Deck Type
Sector
Industry
Deck date
November 2024
Slide
56 of 58
Related slides by other companies
Fusion Pharmaceuticals
IPO
June 2020
reduced tumor growth observed in all dose groups following challenge in contralateral flank tumor mess tumor | Fusion Pharmaceuticals
Taysha
IPO
September 2020
accumulation was significantly reduced in the mid section | Taysha
BAT
Results
April 2022
a pivotal year delivered revenue growth reduced losses leverage enabling more active capital allocation | BAT
Surf Air
Investor Presentation
February 2025
recent improvements have significantly reduced cash requirements and improved stock technicals strengthened balance sheet level set stock technicals substantially lowered costs | Surf Air
Other recent decks by Genprex
See all presentations (3 decks)
Investor Presentation
October 2022
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io